FKACX
Price
$32.31
Change
-$0.40 (-1.22%)
Updated
Jun 13 closing price
Net Assets
4.51B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

FKACX vs RGEBX

Header iconFKACX vs RGEBX Comparison
Open Charts FKACX vs RGEBXBanner chart's image
Franklin Growth Opportunities C
Price$32.31
Change-$0.40 (-1.22%)
VolumeN/A
Net Assets4.51B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
FKACX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FKACX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKACX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. FKACX (4.51B). FKACX (0.00) and RGEBX (0.00) have matching dividends . FKACX was incepted earlier than RGEBX: FKACX (26 years) vs RGEBX (11 years). FKACX (1.66) is less costly to investors than RGEBX (1.09). FKACX is a more actively managed with annual turnover of: 27.49 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than FKACX: RGEBX (250) vs FKACX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. FKACX (-6.59). RGEBX return over 5 years is better than : 45.42 vs. FKACX (-5.99).
FKACXRGEBXFKACX / RGEBX
Total Expense Ratio1.661.09152%
Annual Report Gross Expense Ratio1.661.09152%
Fund Existence26 years11 years-
Gain YTD0.8744.82918%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.51B306B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.597.68-86%
Returns for 3 years16.7751.0133%
Returns for 5 years-5.9945.42-13%
Returns for 10 years8.2065.8712%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd